PharmaCyte Biotech PMCB
NASDAQ PMCB
$0.53 +0.02 (+3.64%)
At close: Aug 21, 2026 · 4:00 PM EDT

PharmaCyte Biotech (PMCB) Net Margin (QoQ) (2010 - 2012)

PharmaCyte Biotech (PMCB) Net Margin (QoQ) (2010 - 2012) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 PharmaCyte Biotech 4.38 Mn 4.38 Mn -

Historic Data

Download Data
DateValue
Oct 31, 2012 220,875.00
Jul 31, 2012 30,897.00
Apr 30, 2012 -693,665.00
Jan 31, 2012 404.00
Oct 31, 2011 126,847.00
Jul 31, 2011 -243,588.00
Apr 30, 2011 -99,353.00
Jan 31, 2011 -8,903.00
Oct 31, 2010 13,758.00